[Acrodermatitis enteropathica (author's transl)].
In connection with the clinical observation of their five patients suffering from AE the authors summarize current questions related to this disease. They examined the function of the cellular immunity in this disease. They call attention to dangers of oxychinoline treatment, and to benefits of zinc administration. They established that the introduction of zinc therapy indicates a progress in the treatment of AE.
D000169:Acrodermatitis / Q000188:drug therapy / Q000276:immunology*; D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes; D007223:Infant; D008286:Malabsorption Syndromes / Q000276:immunology; D008297:Male; D015032:Zinc / Q000172:deficiency / Q000378:metabolism / Q000627:therapeutic use
D006912:Hydroxyquinolines; D015032:Zinc
Zur Frage der Acrodermatitis enteropathica.